Bromadoline

Source: Wikipedia, the free encyclopedia.
Not to be confused with
Bromadol or Bromadiolone
.
Bromadoline
Clinical data
Other namesBromadoline
ATC code
  • none
Identifiers
  • 4-bromo-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]benzamide
JSmol)
  • CN(C)[C@@H]1CCCC[C@H]1NC(=O)C2=CC=C(C=C2)Br
  • InChI=1S/C15H21BrN2O/c1-18(2)14-6-4-3-5-13(14)17-15(19)11-7-9-12(16)10-8-11/h7-10,13-14H,3-6H2,1-2H3,(H,17,19)/t13-,14-/m1/s1
  • Key:UFDJFJYMMIZKLG-ZIAGYGMSSA-N
  (verify)

Bromadoline (U-47931E)[1] is an opioid analgesic selective for the μ-opioid receptor[2] developed by the Upjohn company in the 1970s.[3] The drug has a potency lying between that of codeine and morphine, being slightly stronger than pentazocine.[4] Bromadoline is related to AH-7921 and U-47700.[5]

See also

References

  1. ISBN 978-0-913210-13-0
    .
  2. PMID 3559988
    .
  3. ^ Jacob Szmuszkovicz (4 July 1978). "Patent US4098904 - Analgesic N-(2-aminocycloaliphatic)benzamides". The Upjohn Company.
  4. PMID 2822190
    .
  5. PMID 2999404
    .


Stub icon

This analgesic-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Bromadoline&oldid=1204943788"